Cargando…

Lung cancer screening guidelines are clear but are they being followed?

Detalles Bibliográficos
Autores principales:	Olazagasti, Coral, Bernabe, Carolina, Seetharamu, Nagashree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724650/ https://www.ncbi.nlm.nih.gov/pubmed/33318756 http://dx.doi.org/10.2217/lmt-2020-0015

Ejemplares similares

Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits
por: Olazagasti, Coral, et al.
Publicado: (2021)

Disparities in lung cancer screening rates among the Hispanic/LatinX population
por: Olazagasti, Coral, et al.
Publicado: (2021)

One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population
por: Olazagasti, Coral, et al.
Publicado: (2022)

Implementing physician education to increase lung cancer screening uptake
por: Olazagasti, Coral, et al.
Publicado: (2023)

Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer
por: Olazagasti, Coral, et al.
Publicado: (2022)

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies
por: Olazagasti, Coral, et al.
Publicado: (2020)

SAT-LB102 When the Answer Is Not in the First Look: An Unusual Presentation of Follicular Thyroid Carcinoma
por: Bernabe Ramirez, Carolina, et al.
Publicado: (2019)

Going Back Home: Understanding Physician Migration to the United States
por: Olazagasti, Coral, et al.
Publicado: (2023)

Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients
por: Neumann, Melissa, et al.
Publicado: (2021)

The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America
por: Bernabe-Ramirez, Carolina, et al.
Publicado: (2020)

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data
por: Lee, Chung-Shien, et al.
Publicado: (2021)

New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu, Nagashree, et al.
Publicado: (2017)

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer
por: Wang, Kevin Y, et al.
Publicado: (2021)

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives
por: Fraser, Madison, et al.
Publicado: (2023)

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab
por: Lee, Matthew, et al.
Publicado: (2019)

Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
por: Newman, James, et al.
Publicado: (2020)

Prophylactic antibiotic: The need for clear guidelines
por: Muqarmea, Mohammed Mahdi
Publicado: (2013)

Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer
por: Lee, Chung-Shien, et al.
Publicado: (2020)

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
por: Lee, Chung-Shien, et al.
Publicado: (2020)

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
por: Runcie, Karie, et al.
Publicado: (2018)

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review
por: McGovern, Kerri, et al.
Publicado: (2019)

Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 in vivo experiment
por: Wang, Houlei, et al.
Publicado: (2023)

Work-Life Balance vs. Work-Life Integration: A Young Physician Mother’s Journey
por: Olazagasti, Coral, et al.
Publicado: (2022)

Prostate-specific antigen-based screening: controversy and guidelines
por: Kim, Eric H, et al.
Publicado: (2015)

Lung cancer screening—Marching along …
por: Fong, Kwun M., et al.
Publicado: (2022)

Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Developing CSCO Lung Cancer Practice Guidelines Stratified by Resource Availability and Treatment Value
por: Zhou, Qing, et al.
Publicado: (2016)

NSTEMI treatment: should we always follow the guidelines?
por: van ’t Hof, A. W. J., et al.
Publicado: (2019)

Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines
por: Olivier, Timothée, et al.
Publicado: (2022)

Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
por: Hoyt, Catherine R., et al.
Publicado: (2023)

Creating implementable clinical practice guidelines: the 2020 Focused Updates to the National Heart, Lung, and Blood Institute’s Asthma Management Guidelines
por: Shero, Susan T., et al.
Publicado: (2023)

HIV Nuclear Entry: Clearing the Fog
por: Shah, Vaibhav B., et al.
Publicado: (2010)

Commentary: “I can see clearly now!” Indocyanine green virtual-assisted lung mapping (ICG-VAL-MAP) and the future identification of small lung nodules
por: Beqari, Jorind, et al.
Publicado: (2021)

Nicotine and Insulin Resistance: When the Smoke Clears
por: Bajaj, Mandeep
Publicado: (2012)

Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2016)

COVID-19 screening during fertility treatment: how do guidelines compare against each other?
por: Papathanasiou, Athanasios
Publicado: (2020)

Guidelines for Exposure Assessment in Health Risk Studies Following a Nuclear Reactor Accident
por: Bouville, André, et al.
Publicado: (2013)

Commentary: Preventing postoperative surgical-site infections in cardiac surgery: Just follow the guidelines
por: Lazar, Harold L.
Publicado: (2021)

Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
por: Peng, Terrance, et al.
Publicado: (2022)

What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
por: Bradley, Stephen H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s87pff26bjprgvr7peiado4snm